DCOE News

  • Thursday, December 06, 2018 New beta cell biomarker discovered: What does this mean for future diabetes research?

    New beta cell biomarker discovered: What does this mean for future diabetes research?

    New research has identified a biomarker for insulin-producing beta cells, as reported in the latest Cell Metabolism journal.  The laboratory of UMass Diabetes Center of Excellence (DCOE) co-director Dale Greiner, PhD, collaborated by providing some of the unique immunodeficient mice that allowed for the in-vivo imaging studies.  The UMass DCOE is among a few in the world studying human beta cells, the insulin producing cells found only in the pancreas.  FULL STORY

  • Monday, November 26, 2018 Laura Alonso, MD elected into the American Society for Clinical Investigation

    Laura Alonso, MD elected into the American Society for Clinical Investigation

    Laura Alonso, MD, The George F. and Sybil H. Fuller Term Chair in Diabetes, Director of Beta Cell Biological Studies at the UMass Diabetes Center of Excellence, and Professor of Medicine at University of Massachusetts Medical School, has been elected to the American Society for Clinical Investigation (ASCI).  One of the nation’s oldest and most prestigious medical honor societies, ASCI supports the work of top physician-scientists whose biomedical research translates findings in the laboratory to the advancement of clinical practice.  LEARN MORE

  • Tuesday, November 13, 2018 The laboratories of Michael Brehm, PhD and Dale Greiner, PhD were published in the November issue of The FASEB Journal

    The laboratories of Michael Brehm, PhD and Dale Greiner, PhD were published in the November issue of The FASEB Journal

    The article is titled: "Lack of acute xenogeneic graft-versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression."  LEARN MORE

  • Friday, November 02, 2018 UMass Diabetes Center of Excellence Patient Care Clinic receives a $10.5K gift from grateful family

    UMass Diabetes Center of Excellence Patient Care Clinic receives a $10.5K gift from grateful family

    The First Annual Joe “Nuzzy” Memorial Golf Tournament raised $10,500, which was generously donated to the UMass Memorial Diabetes Center of Excellence (DCOE), to be used for continued patient care.  The family wants the money to help others being treated for diabetes at UMass Memorial.  They recently toured our research laboratories, and were impressed with what they saw.   
    FULL STORY

  • Monday, October 29, 2018 Two laboratories receive $2.5M grant to advance potential therapy for type 2 diabetes

    Two laboratories receive $2.5M grant to advance potential therapy for type 2 diabetes

    Silvia Corvera, MD, and Michael Czech, PhD, are investigating whether technologies developed in their labs will harness beige fat’s ability to burn energy and accelerate metabolism in order to improve the body’s response to sugar and lower blood glucose levels.  READ MORE

  • Wednesday, October 24, 2018 Staff Spotlight: Inpatient Diabetes Care at UMass Diabetes Center of Excellence

    Staff Spotlight: Inpatient Diabetes Care at UMass Diabetes Center of Excellence

    One third of patients that enter the hospital have diabetes.  Our inpatient team sees the many who already have diabetes, and are undergoing a surgery or procedure, or are being treated for another chronic illness, or complication from diabetes.  They also work closely with those getting diagnosed with diabetes for the first time, ensuring that they learn everything needed to leave with “diabetes survival skills.”  Our inpatient team ensures the transition home is smooth, by coordinating necessary medication prescriptions and follow-up appointments. LEARN MORE

  • Thursday, September 06, 2018 Man getting a flu shot

    Importance of a Flu Shot for People Living With Diabetes

    People type 1 and type 2 diabetes, even when well-managed, are at high risk of serious flu complications.  The beginning of September is considered the best time to get the vaccine.  The flu shot is a safe and effective way to prevent or reduce the severity of previously mentioned complications.  LEARN MORE

  • Tuesday, August 28, 2018 Understanding How Viruses Trigger Type 1 Diabetes

    Understanding How Viruses Trigger Type 1 Diabetes

    UMass Medical School infectious disease and immunology expert Jennifer Wang, MD, and postdoc Natasha Qaisar, PhD, hope to move closer to better understanding type 1 diabetes, thanks to a grant from the National Institutes of Health. They will work with a new type 1 diabetes animal model to identify pathways which could be stopped in order to prevent the disease from developing. FULL STORY

  • Tuesday, August 07, 2018 Unexpected Cell Population Gives Fat a Brake

    Unexpected Cell Population Gives Fat a Brake

    UMass Diabetes Center of Excellence researcher, David A. Guertin, PhD, recently had a News & Views article published in Nature, the world's leading multidisciplinary science journal.  Fat tissue has a remarkable capacity for growth.  Dr. Guertin responds to new research data and explains why it is exciting to the future of combating obesity.  READ MORE

  • Thursday, July 12, 2018 The Importance of Language in Diabetes

    The Importance of Language in Diabetes

    The words we use to describe something shapes the way others perceive and value that thing.  The culture in diabetes tends to be the disease defines the person, such as, “he/she is a diabetic.”  Changing that language to “he is living with diabetes” or “she is thriving with her diabetes care” can make a world of difference.  “A1c and blood glucose numbers should simply be used as data to devise a treatment plan and action plan,” says Kristin L. MacGregor, PhD, a Behavioral Psychologist at the UMass Memorial Medical Center Diabetes Center of Excellence. “Not a definition of the person.  The truth is, you have the power to manage the disease, it doesn’t control you.”  READ THE ENTIRE ARTICLE

  • Monday, July 09, 2018 Getting Started with Diabetes Education

    Staff Spotlight: The Role of a Diabetes Educator

    Diabetes Education has been shown to lower A1c by as much as 1% (similar to adding a medication but without the side effects).  Research shows that people who have received diabetes education are more likely to utilize primary care and preventative services, take medications as prescribed and control their blood glucose, blood pressure and cholesterol levels.  As a result, those people have lower health costs.  The UMass Diabetes Center of Excellence is pleased to welcome our new Manager of Diabetes Education, Cheryl Barry, RN, MS, CDE.   We have an extensive education program with individual sessions available as well as group workshops which cover a variety of topics.  LEARN MORE

     

  • Friday, June 29, 2018 The Effects of Extreme Heat on Diabetes

    The Effects of Extreme Heat on Diabetes

    Hot weather can affect your blood glucose (blood sugar) levels, potentially cause it to rise or fall, causing hypoglycemia or hyperglycemia.  It is recommended that you check your blood glucose levels more often during hot weather.   It's important to stay hydrated during extreme heat.  Drink plenty of water and avoid sugary drinks, coffee and alcohol.  Here are some other important tips about managing diabetes in hot weather.  LEARN MORE

  • Friday, June 22, 2018 Exciting New Diabetes Management Technology

    Exciting New Diabetes Management Technology

    This week, the US Food and Drug Administration (FDA) approved Tandem Diabetes Care’s new t:slim X2 Insulin pump with Basal-IQ technology, Medtronic’s MiniMed(TM) 670G system in patients with type 1 diabetes seven years of age and older, and the first ever implantable continuous glucose monitoring system (CGM).  LEARN MORE

  • Thursday, June 21, 2018

    BCG Trial Study Reaction

    Researchers at Massachusetts General Hospital (MGH) have published a study which claims that a nearly century old vaccine against tuberculosis, may help people with type 1 diabetes.  News of this study is being carried throughout the media with attention grabbing headlines such as “Generic Vaccine Could Reverse Type 1 Diabetes” and “Common Vaccine May Reverse the Effects of Type 1 Diabetes.”  UMass Diabetes Center of Excellence scientists and clinicians recommend... READ MORE

  • Wednesday, June 20, 2018 The research lab of René Maehr, PhD was published with the cover story in the June 19 issue of Immunity.  A Single-Cell Transcriptomic Atlas of Thymus Organogenesis Resolves Cell Types and Developmental Maturation highlights their study on thymus development.

    The Maehr Lab's Study on Thymus Development Received the Cover Story in the June Issue of Immunity

    The research lab of René Maehr, PhD, was published with the cover story in the June 19 issue of Immunity.  A Single-Cell Transcriptomic Atlas of Thymus Organogenesis Resolves Cell Types and Developmental Maturation highlights their study on thymus development.  LEARN MORE 

  • Wednesday, June 13, 2018 Staff Spotlight: Nurse Practitioners in Diabetes Care

    Staff Spotlight: Nurse Practitioners in Diabetes Care

    Many patients do not understand the role and capabilities of a Nurse Practitioner (NP) when it comes to their diabetes care. NPs are taught two models of care, both the medical model and the nursing model.  The scope of practice of a Nurse Practitioner varies from state to state.  Meet one of the DCOE NPs and find out how she provides care to patients at the UMass Diabetes Center of Excellence.  LEARN MORE

  • Tuesday, June 05, 2018 Insulin Access and Affordability: The Rising Cost of Treatment

    Insulin Access and Affordability: The Rising Cost of Treatment

    The average list price of insulin has nearly tripled between 2002 and 2013.  The American Diabetes Association recently provided new recommendations for improving insulin access and affordability.  The policy statement addresses four key areas. READ MORE

  • Tuesday, May 29, 2018 MD/PhD candidate Rachel Stamateris

    MD/PhD candidate Rachel Stamateris named Ruth L. Kirschstein Fellow

    Rachel Stamateris, an MD/PhD candidate at University of Massachusetts Medical School, has been awarded a prestigious Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship for dual-doctoral degree students, from the National Institute of Diabetes and Digestive and Kidney Diseases.  Her fellowship experience is intended to enhance Rachel’s integrated research and clinical training as predoctoral student.  Over the next four years, this award will help to sponsor her research and promote her development into a productive, independent physician/clinician-scientist.  READ MORE

  • Friday, May 18, 2018 Dr. Nwosu

    New study of youth with type 1 diabetes connects ‘honeymoon period’ with lower LDL cholesterol

    A new study by UMass Diabetes Center of Excellence physician-scientist Benjamin Nwosu, MD, finds that children with type 1 diabetes who experienced a partial clinical remission, or “honeymoon phase,” had significantly lower low-density lipoprotein (LDL), or “bad” cholesterol, five years after diagnosis. Children who do not undergo this honeymoon may experience worse outcomes over the long term—including cardiovascular disease.  READ MORE

  • Wednesday, May 16, 2018 Alonso Lab Published in the Latest Issue of Diabetes

    Alonso Lab Published in the Latest Issue of Diabetes

    Type 2 diabetes (T2D) risk has a strong genetic component.  Genetic studies have already linked a region of the human genome called CDKN2A/B with the risk of T2D, but how and why it increases T2D risk remains unknown.  Our research, funded by a grant by the American Diabetes Association in collaboration with the Order of the Amaranth, took an in-depth look at the specific and subtle ways that these genes impact the insulin-producing pancreatic beta cells.  READ MORE

  • Wednesday, May 09, 2018 State of Behavioral Health Integration in U.S. Diabetes Care: How Close Are We to ADA Recommendations?

    State of Behavioral Health Integration in U.S. Diabetes Care: How Close Are We to ADA Recommendations?

    In 2016 the American Diabetes Association recommended including behavioral/mental health professionals on the care team for people living with diabetes. This recommendation was also included in the ADA’s 2018 Standards of Medical Care in Diabetes.  DCOE Behavioral Psychologists, Samantha A. Barry, PhD and Kristin L. MacGregor, PhD, were published in the April 2018 issue of Diabetes Care, examining exactly how close diabetes healthcare in the U.S. really is to meeting those recommendations.  READ MORE

  • Monday, May 07, 2018 Low-Carb Diet Might Aid People With Type 1 Diabetes

    Low-Carb Diet Might Aid People With Type 1 Diabetes

    David Harlan, MD, co-director of the UMass Diabetes Center of Excellence, was quoted in today's New York Times article about a new study published in the journal Pediatrics which found that children and adults with type 1 diabetes who followed a very low-carb, high-protein diet for an average of just over two years, combined with insulin at smaller doses than typically required on a normal diet, had “exceptional” blood sugar control and low rates of major complications.  "Perhaps the surprise is that for this large number of patients it is much safer than many experts would have suggested.  I’m excited to see this paper,” Dr. Harlan added. “It should reopen the discussion about whether this is something we should be offering our patients as a therapeutic approach.”  READ THE FULL ARTICLE

  • Thursday, May 03, 2018 DCOE Scientist Elected to the National Academy of Sciences

    DCOE Scientist Elected to the National Academy of Sciences

    Roger J. Davis, PhD has been elected to the National Academy of Sciences.  Membership in the NAS is one of the highest honors bestowed upon a scientist in the United States. He joins four UMass Medical School colleagues who have received membership in recognition of their for outstanding contributions to original research.  His work to explain the molecular mechanism by which inflammation contributes to diabetes, cancer and stroke has been among the most important in this field for more than two decades. READ MORE

  • Tuesday, April 10, 2018

    Supreme Court Justice Sonia Sotomayor Wears CGM to Work

    When four electronic pings sounded during a Supreme Court argument, the device belonged to Justice Sonia Sotomayor and was alerting the justice that her blood sugar was urgently low.  The 63-year-old justice has had diabetes since childhood, but the sound was the first public notice that she was using a continuous glucose monitor.  READ MORE

  • Wednesday, March 28, 2018 Newly FDA Approved Continuous Glucose Monitors (CGM) to Better Manage Blood Glucose

    Newly FDA Approved Continuous Glucose Monitors (CGM) to Better Manage Blood Glucose

    The U.S. Food and Drug Administration has approved new integrated technology to help people with diabetes control their blood glucose. 
    READ MORE

  • Wednesday, March 14, 2018 Clinical Diabetes Centers of Excellence: A Model for Future Adult Diabetes Care

    Clinical Diabetes Centers of Excellence: A Model for Future Adult Diabetes Care

    Although diabetes research centers are well defined by National Institutes of Health, there is no clear definition for clinical Diabetes Centers of Excellence (DCOEs). There are multiple clinical diabetes centers across the United States, however, it is not clear what defines a DCOE from a clinical perspective and what the future will be for these centers. Dr. David Harlan, Co-Director of the UMass Diabetes Center of Excellence, co-authored an article published in The Journal of Clinical Endocrinology & Metabolism, in which they propose a framework to guide advancement for DCOEs.  READ MORE

  • Monday, March 12, 2018 Alpha Cell Function and Gene Expression Are Compromised in Type 1 Diabetes

    Alpha Cell Function and Gene Expression Are Compromised in Type 1 Diabetes

    As part of a research team lead by Drs. Marcela Brissova and Alvin C. Powers (Vanderbilt University), the research laboratories of UMass Diabetes Center of Excellence co-directors, David Harlan, MD and Dale Greiner, PhD, in collaboration with established investigators from a consortium of institutions throughout the country, have been published in the latest issue of Cell Reports. READ MORE

  • Thursday, March 08, 2018 Boston Ithaca Islet Club Annual Meeting to be Held at UMass Medical School

    Boston Ithaca Islet Club Annual Meeting to be Held at UMass Medical School

    Dr. Laura Alonso will be hosting the upcoming Boston Ithaca Islet Club Annual Meeting, the weekend of April 28-29, at the UMass Diabetes Center of Excellence. The two-day forum gathers scientists researching pancreatic islet function, development, growth, immunology and transplantation.  Participants include graduate students, post-doctoral fellows and established investigators from academic centers around the northeast United States and Canada.  READ MORE

  • Wednesday, March 07, 2018 Dr. Nancy Morris receives Excellence in Nursing Education Award from American Nursing Association  Massachusetts

    Dr. Nancy Morris receives Excellence in Nursing Education Award from American Nursing Association  Massachusetts

    Congratulations to Dr. Nancy Morris, Adult Nurse Practitioner in the UMass Diabetes Center, for winning the Excellence in Nursing Education Award.  The award honors nurse educators for teaching, research and practice. It recognizes nurse educators who use innovative approaches to facilitate learning and professional development. READ MORE 

  • Friday, March 02, 2018 Dr. David Harlan

    Dr. Harlan Weighs In On New Community HELP Program

    UMass Memorial Health Care is now part of an easy-to-use website that allows the community and service providers to search for and refer to programs they need. The website, CommunityHELP.com, stands for Health and Everyday Living Programs.  Dr. David M. Harlan, co-director of the UMass Diabetes Center of Excellence, feels the website will support patients’ ability to help themselves. “Are the patients engaged? Because if they’re engaged, they’ll do better.”  READ MORE

  • Wednesday, February 28, 2018 Dr. Kent receives Pioneer Award from the Network for Pancreatic Organ Donors with Diabetes

    Dr. Kent receives Pioneer Award from the Network for Pancreatic Organ Donors with Diabetes

    Sally C. Kent, Ph.D., Associate Professor of Medicine in the Diabetes Division, Diabetes Center of Excellence at UMass Medical School, was recognized by the Network for Pancreatic Organ Donors with Diabetes (nPOD) with a Pioneer Award for her “continued dedication to create a world free of Type 1 Diabetes.”  Jenny Aurielle B. Babon, Ph.D., a Post Doctoral Associate in the Kent Lab, gave a poster and oral presentation at the nPOD Annual Scientific Meeting about their findings looking at the white blood cells from within the islets of a recent-onset T1D donor.  The donor had been diagnosed with type 1 diabetes just five months before he passed away, at the age of 23.  READ MORE

  • Friday, October 27, 2017 Dr. Nwosu, MD

    Benjamin Nwosu confirms accuracy of simple method to detect honeymoon period in children newly diagnosed with type 1 diabetes

    Newly diagnosed children with type 1 diabetes sometimes experience a “honeymoon period” during which they are still secreting some insulin on their own and their blood glucose levels can temporarily be restored to at or near normal levels.  A study conducted by UMass Diabetes Center of Excellence physician-scientist Benjamin Nwosu, MD, has confirmed the accuracy of a new, simple method to determine whether children newly diagnosed with type 1 diabetes are experiencing this beneficial partial clinical remission.  READ MORE

  • Monday, February 13, 2017 Researchers at UMMS are studying how  beige fat may be able to help speed up metabolism to treat obesity, diabetes and heart disease.

    Researchers at UMMS are studying how beige fat may be able to help speed up metabolism to treat obesity, diabetes and heart disease.

    What is beige fat and what does it do?  Sylvia Corvera, MD explains how UMass researchers are growing these cells and looking into the potential of using them to help people lose weight.  CLICK TO VIEW VIDEO

  • Tuesday, December 20, 2016 UMass Diabetes Center of Excellence Patients Participated in "Artificial Pancreas" Study

    UMass Diabetes Center of Excellence Patients Participated in "Artificial Pancreas" Study

    The bionic pancreas system developed by Boston University (BU) investigators proved better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in patients with type 1 diabetes living at home, with no restrictions, over 11 days. The report of a clinical trial led by a Massachusetts General Hospital (MGH) along with three other institutions, including the University of Massachusetts Medical School DCOE, is receiving advance online publication in The Lancet READ MORE

  • Thursday, December 01, 2016 New Emphasis on Health Behaviors and Diabetes

    New Emphasis on Health Behaviors and Diabetes

    The UMass Diabetes Center of Excellence is one of five nationally recognized institutions in the U.S. chosen for a collaborative training program to increase capacity in diabetes psychology. The program will train postdoctoral fellows for one year.  Samantha Barry, PhD, will work with Dr. Kristin MacGregor to improve health behaviors and general mental health as they relate to diabetes management.  READ MORE

  • Sunday, November 13, 2016 UMass DCOE Nurse Practitioner Sean Collins Joins the United States Defense Health Agency

    UMass DCOE Nurse Practitioner Sean Collins Joins the United States Defense Health Agency

    Distinguished DCOE nurse practitioner, Sean Collins, PhD, UMMS Assistant Professor in the Graduate School of Nursing, has been promoted to U.S. Army Reserves Brigadier General (BG) and will serve as a principal advisor to the Pentagon’s Director of Health Affairs on Guard and Reserve matters. BG Collins has served on the forefront of the diabetes epidemic for more than 30 years.  FULL STORY

  • Sunday, November 13, 2016 The New OCT Angiography Machine is Great News for UMass Diabetes Patients

    The New OCT Angiography Machine is Great News for UMass Diabetes Patients

    A new cutting-edge Optical Coherence Tomography (OTC) machine is now available to UMass patients at the Hahnemann Campus.  Themachine allows clinicians to observe fine details of the normal and abnormal retinal vasculature affected by diabetic retinopathy. A non-invasive technology with no dye required provides a huge advantage for patients who can now have an advanced retinal exam as part of their diabetes care.

    The OCT machine uses a unique algorithm that detects movement of red blood cells and can separate and visualize different layers of the retina and choroid vasculature. The software has a color coded option that allows depth visualization of the retinal blood flow, giving clinicians an opportunity to look at various retinal diseases from a completely different perspective. Clinician Scientists in the Department of Ophthalmology & Visual Sciences at the University of Massachusetts  are looking forward to making new discoveries that will change the way they treat and diagnose diabetic retinopathy. 

    LEARN MORE AND SEE PHOTOS HERE

  • Monday, October 31, 2016 Kent Lab

    UMMS researchers isolate immune cells from the islets of donors with type 1 diabetes

    In a highly collaborative effort, scientists at UMass Medical School have isolated and characterized a large bank of live islet-infiltrating T cells directly from the islets of tissue donors with type 1 diabetes. The findings, published in Nature Medicine, have direct implications for the design of therapies and preventative strategies for those with type 1 diabetes and those at risk for developing it.  Using live islets from nine type 1 diabetic donors, which is the largest cohort studied thus far, Sally C. Kent, PhD, assistant professor of medicine in the Diabetes Center of Excellence, and Jenny Aurielle B. Babon, PhD, postdoctoral fellow, sorted live lymphocytes from the islets by fluorescence activated cell sorting (FACS), and also used an improved tissue culture method they developed to grow lymphocytes from the islets. Overall, Dr. Kent derived 236 T cell lines from the islets and analyzed the function of 50 lines, discovering the specific reactivities of 18 lines.  READ MORE

  • Monday, September 26, 2016 UMass Medical School hosts American Diabetes Association Step Out Walk to Stop Diabetes

    UMass Medical School hosts American Diabetes Association Step Out Walk to Stop Diabetes

    UMass Diabetes Diabetes Center of Excellence once again hosted the Central MA Step Out Walk to Stop Diabetes.  The signature fundraising event for the American Diabetes Association took place on the UMass Medical School University Campus.  More than 1000 people participated, including DCOE faculty, staff and families.  Entertainment included representatives from the Red Sox, Patriots, New England Revolution, Worcester Bravehearts, and Worcester Railers.  VIEW PHOTOS 

  • Wednesday, September 14, 2016 Dr. David Harlan invited to judge the first Diabetes Innovation Challenge

    Dr. David Harlan invited to judge the first Diabetes Innovation Challenge

    The DCOE co-director, Dr. David Harlan, will serve as a judge for the Diabetes Innovation Challenge that seeks to find transformational advancements in diabetes. The Challenge is organized by the Massachusetts Medical Device Development Center (M2D2), in partnership with T1D Exchange, a nonprofit focused on accelerating innovations that improve outcomes in type 1 diabetes, present the first Diabetes Innovation Challenge. This exciting multi-staged event is an opportunity to identify, support, and incubate transformational innovations in types 1 and 2 diabetes.  LEARN MORE

  • Friday, July 29, 2016 Dr. Louis Messina fixes rare condition for the second time on the same patient

    Dr. Louis Messina fixes rare condition for the second time on the same patient

    Louis Messina, MD, UMass Memorial Medical Center's Division Chief for Vascular Surgery and an investigator at the Diabetes Center of ExCellence, performed a second surgery on a young woman with middle aortic syndrome, a disease found in less than 1 in 100,000 people.  He first performed a bypass on when she was 3 years old.  It was only expected to last about 10 years.  At age 21, she asked him to once again perform the surgery.  Dr. Messina leads the only team in the northeast that can perform this risky surgery.  FULL STORY AND PHOTOS

  • Friday, July 15, 2016 Agata Jurczyk selected for Diabetes Research Connection Funding

    Agata Jurczyk selected for Diabetes Research Connection Funding

    Diabetes Research Connection selected UMass Diabetes of Excellence scientist Agata Jurczyk, PhD, for a new study aiming to identify biomarkers for susceptibility to both type 1 diabetes (T1D) and mental disorders. Recent studies showed that patients with diabetes have a much higher likelihood of depression, and young people with T1D had 11 times the suicide rate.  The goal of her research is to identify genetic signatures in white blood cells that distinguish non-progressor T1D patients, and T1D patients that do progress to psychiatric illness.  PROJECT DETAILS AND VIDEO

  • Wednesday, March 16, 2016 Sally Kent Recognized for Collaborative Research

    Sally Kent Recognized for Collaborative Research

    Sally C. Kent, PhD, assistant professor of medicine, was recently recognized at the Network for Pancreatic Donors with Diabetes (nPOD) 8th Annual Scientific Session in Miami as a “champion of the collaborative spirit.” Dr. Kent was presented with the Spirit of nPOD award for her work with the members of and projects within nPOD.  FULL STORY

  • Thursday, December 24, 2015 News Image

    DCOE co-director Dale Greiner, PhD collaborates with researchers from Harvard and MIT on potential diabetes treatment

    UMass Medical School investigator Dale Greiner, Ph. D, collaborated with researchers from Harvard and MIT on a novel approach to shielding pancreatic beta cells from attacks by the human immune system. The entire process was tested at the UMMS on immunodefficient humanized mice.  LEARN MORE